| 2017-12 | Current therapy and new drugs: A road to personalized treatment of myelodysplastic syndromes | Parisi, Sarah; Ratti, Stefano; Mongiorgi, Sara; Suh, Pann-Ghill; Manzoli, Lucia; McCubrey, James A.; Cocco, Lucio; Follo, Matilde Y.; Finelli, Carlo | ARTICLE | 2 |
| 2016-06 | Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromes | Mongiorgi, Sara; Finelli, Carlo; Yang, Young Ryoul; Clissa, Cristina; McCubrey, James A.; Billi , Anna Maria; Manzoli, Lucia; Suh, Pann-Ghill; Cocco, Lucio; Follo, Marilde Y. | ARTICLE | 852 |
| 2018-02 | Nuclear translocation of PKC-alpha is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs) | Poli, Alessandro; Ratti, Stefano; Finelli, Carlo; Mongiorgi, Sara; Clissa, Cristina; Lonetti, Annalisa; Cappellini, Alessandra; Catozzi, Alessia; Barraco, Marilena; Suh, Pann-Ghill; Manzoli, Lucia; McCubrey, James A.; Cocco, Lucio; Follo, Matilde Y. | ARTICLE | 264 |
| 2020-11 | Phospholipase C beta1 (PI-PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron-induced oxidative stress in myelodysplastic syndromes (MDS) | Cappellini, Alessandra; Mongiorgi, Sara; Finelli, Carlo; Fazio, Antonietta; Ratti, Stefano; Marvi, Maria Vittoria; Curti, Antonio; Salvestrini, Valentina; Pellagatti, Andrea; Billi, Anna Maria; Suh, Pann-Ghill; McCubrey, James A.; Boultwood, Jacqueline; Manzoli, Lucia; Cocco, Lucio; Follo, Matilde Y. | ARTICLE | 4 |
| 2019-09 | Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes | Follo, Matilde Y.; Pellagatti, Andrea; Armstrong, Richard N.; Ratti, Stefano; Mongiorgi, Sara; De Fanti, Sara; Bochicchio, Maria Teresa; Russo, Domenico; Gobbi, Marco; Miglino, Maurizio; Parisi, Sarah; Martinelli, Giovanni; Cavo, Michele; Luiselli, Donata; McCubrey, James A.; Suh, Pann-Ghill; Manzoli, Lucia; Boultwood, Jacqueline; Finelli, Carlo; Cocco, Lucio | ARTICLE | 80 |
